Skip to main content
Premium Trial:

Request an Annual Quote

NIH Grants for Pharmacogenomics Research, FY 05 March 7 -- April 17*

Premium
NIH Grants for Pharmacogenomics Research,
FY '05 March 7 — April 17*
City, State
Organization Name
Principal Investigator
Award
Title

CALIFORNIA
San Diego

Illumina, Inc. Oliphant, Arnold R
$76,000
Highly Parallel SNP Genotyping for a Haplotype Map
Mountain View Perlegen Sciences, Inc. Stokowski, Renee P
$1,659,385
Signature SNPs
to distinguish Yersinia pestis strains
Los Angeles University of California Los Angeles David Geffen School
of Medicine
Black, Douglas L
$415,803
Genomic Measurement of Alternative Splicing by DNA Array
Los Angeles University of California Los Angeles Liao,
James C
$1,041,832
Automated Chip-Based Metabolomic Analysis
Los Angeles University of California Los Angeles David Geffen School of Medicine Licinio, Julio
$289,962
UCLA Pharmacogenetics and Pharmacogenomics Research Group
La Jolla University of California San Diego Bourne,
Philip E
$1,080,622
Tools & Data Resources in Support of Structural Genomics
La Jolla University of California San Diego School of Medicine Kelsoe,
John R
$621,364
Genomic studies of bipolar disorder and chromosome 22
San Francisco University of California San Francisco School of Medicine Hamilton, Steven P
$1,839,941
Pharmacogenomics of Antidepressant Response
San Francisco University of California San Francisco School of Medicine Kashanisabet, Mohammed
$297,317
Validation of genomic targets
in melanoma
FLORIDA
Tampa
H. Lee Moffitt Cancer Center and Research Institute Bepler, Gerold
$293,776
Pharmacogenomics of Neoadjuvant Gemcitabine-Pemetrexed
ILLINOIS
Chicago
Loyola University Chicago Stritch School of Medicine Zhu, Xiaofeng
$294,071
LD Mapping Using Haplotype Block: Methods & Application
MASSACHUSETTS
Boston
CBR Institute for Biomedical Research Fraser, Patricia A
$283,500
Innate immune gene SNPS in African-Americans with RA
Boston Dana-Farber Cancer Institute Johnson, Bruce E
$296,779
EGFR Mutations in non-Small Cell Lung Cancer
Boston Tufts University School of Medicine Jay, Daniel G
$139,884
Proteome Signatures and Target Validation in Lymphomas
MINNESOTA
Minneapolis
University of Minnesota Twin Cities Pan, Wei
$174,500
Statistical Methods for Genomic and Proteomic Data
NEW HAMPSHIRE
Hanover
Dartmouth College Medical School Hwa, John
$319,550
Pharmacogenetics of the human prostacyclin receptor.
NEW YORK
Cold Spring Harbor
Cold Spring Harbor Laboratory Wigler,
Michael H
$518,769
Genomics of Human Cancer
Buffalo Roswell Park Cancer Institute Corporation Moysich,
Kirsten B
$84,355
Use of Stored Bone Marrow Samples for Pharmacogenetic
New York Sloan-Kettering Institute for Cancer Research Rizvi,
Naiyer A
$143,964
Correlation of EGFR Mutations and Response to Gefitinib
Albany Wadsworth Center Spivack, Simon Daniel
$153,011
Individual Promoter SNP and CpG Methylation Signatures

NORTH CAROLINA

Durham

Duke University School of Medicine Lawson, Jeffrey H
$154,000
Genomics of Peripheral Arterial Disease
Raleigh North Carolina State University Raleigh Anholt, Robert Rh
$434,740
Comparative Genomics of Glaucoma
OHIO
Cincinnatti
Children's Hospital Medical Center, Cincinnati Katz,
Jonathan D
$271,488
Using Genomics to Understand Autoimmune Diabetes
TENNESSEE
Memphis
St. Jude's Children's Research Hospital Schuetz, Erin G
$294,060
PXR: Regulation and Pharmacogenomics
TEXAS
Houston
Baylor College of Medicine Nelson, David
$596,374
Sequence and Haplotypes for Analysis of Cancer Genes
Houston University of Texas MD Anderson Cancer Center Cinciripini, Paul M
$540,814
Pharmacogenetics, Emotional Reactivity & Smoking
VIRGINIA
Williamsburgh
Incogen, Inc. Sasinowski, Maciek
$1,202,334
Proteomics software package for the detection of cancer
WASHINGTON Seattle University of Washington School of Medicine Schellenberg, Gerard D
$267,750
Genomic Analysis of Alzheimer's Disease Genes
Seattle University of Washington Thummel, Kenneth E
$440,029
Pharmacogenomics of ADRs: Calcineurin Inhibitor Toxicity
*SOURCE: US National Institutes of Health

Filed under